Mirror Biofeedback Rehabilitation after Administration of Single-Dose Botulinum Toxin for Treatment of Facial Synkinesis

被引:43
作者
Azuma, Takahiro [1 ]
Nakamura, Katsuhiko [1 ]
Takahashi, Mika [1 ]
Ohyama, Seizo [2 ]
Toda, Naoki [2 ]
Iwasaki, Hidetaka [3 ]
Kalubi, Bukasa [1 ]
Takeda, Noriaki [1 ]
机构
[1] Univ Tokushima, Dept Otolaryngol, Sch Med, Tokushima 7708503, Japan
[2] Tokushima Prefectural Cent Hosp, Dept Otolaryngol, Tokushima, Japan
[3] Tokushima Red Cross Hosp, Dept Otolaryngol, Tokushima, Japan
关键词
facial synkinesis; biofeedback rehabilitation; botulinum toxin; PALSY; INJECTION;
D O I
10.1177/0194599811424125
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective. The efficacy of facial biofeedback rehabilitation with a mirror after administration of a single dose of botulinum A toxin on facial synkinesis was examined in patients with chronic facial palsy. Study Design. Prospective clinical study. Setting. University hospital. Subjects and Methods. The present study includes 8 patients with Bell palsy and 5 with herpes zoster oticus showing facial synkinesis. A single dose of botulinum A toxin was used as the initial process of facial rehabilitation. Patients then continued a daily facial biofeedback rehabilitation with a mirror at home. They were instructed to keep their eyes symmetrically open using a mirror during mouth movements. The degree of oralocular synkinesis was evaluated by the degree of asymmetry of eye opening width during mouth movements (% eye opening). Results. After administration of a single dose of botulinum A toxin, temporary relief of facial synkinesis was observed in all patients. Patients were then instructed to continue the facial biofeedback rehabilitation with a mirror for 10 months. The mean values of the percent of eye opening during 3 designated mouth movements that included lip pursing /u:/, teeth baring /i:/, and cheek puffing /pu:/ increased significantly after 10 months when the effects of botulinum A toxin had completely disappeared. Conclusion. These findings demonstrate that facial biofeedback rehabilitation with a mirror after administration of a single dose of botulinum A toxin is a long-lasting treatment of established facial synkinesis in patients with chronic facial palsy.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 13 条
[1]   Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy [J].
Armstrong, MWJ ;
Mountain, RE ;
Murray, JAM .
CLINICAL OTOLARYNGOLOGY, 1996, 21 (01) :15-20
[2]   Botulinum toxin for aberrant facial nerve regeneration: Double-blind, placebo-controlled trial using subjective Endpoints [J].
Borodic, G ;
Bartley, M ;
Slattery, W ;
Glasscock, M ;
Johnson, E ;
Malazio, C ;
Goodnough, M ;
Acquadro, M ;
McKenna, M .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2005, 116 (01) :36-43
[3]   Facial neuromuscular retraining for oral synkinesis [J].
Brach, JS ;
VanSwearingen, JM ;
Lenert, J ;
Johnson, PC .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1997, 99 (07) :1922-1931
[4]   SPROUTING OF MAMMALIAN MOTOR-NERVE TERMINALS INDUCED BY INVIVO INJECTION OF BOTULINUM TYPE-D TOXIN AND THE FUNCTIONAL RECOVERY OF PARALYZED NEUROMUSCULAR-JUNCTIONS [J].
COMELLA, JX ;
MOLGO, J ;
FAILLE, L .
NEUROSCIENCE LETTERS, 1993, 153 (01) :61-64
[5]   Usefulness of BFB/EMG in facial palsy rehabilitation [J].
Dalla Toffola, E ;
Bossi, D ;
Buonocore, M ;
Montomoli, C ;
Petrucci, L ;
Alfonsi, E .
DISABILITY AND REHABILITATION, 2005, 27 (14) :809-815
[6]   Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy [J].
Dalla Toffola, Elena ;
Furini, Francesco ;
Redaelli, Carla ;
Prestifilippo, Elena ;
Bejor, Maurizio .
DISABILITY AND REHABILITATION, 2010, 32 (17) :1414-1418
[7]   The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans [J].
Eleopra, R ;
Tugnoli, V ;
DeGrandis, D .
MOVEMENT DISORDERS, 1997, 12 (01) :89-94
[8]   Management of synkinesis [J].
Husseman, Jacob ;
Mehta, Ritvik P. .
FACIAL PLASTIC SURGERY, 2008, 24 (02) :242-249
[9]   Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation [J].
Ito, H. ;
Ito, H. ;
Nakano, S. ;
Kusaka, H. .
ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (04) :271-274
[10]  
May M., 2000, FACIAL NERVE, P431